Brief: Knight Therapeutics Inc Says Co, Medison Biotech (1995) Ltd Have Agreed To Separate Their Businesses

Knight Therapeutics

21/11/2019 22:06

Nov 21 (Reuters) - Knight Therapeutics Inc  GUD.TO :
    * KNIGHT THERAPEUTICS INC - CO, MEDISON BIOTECH (1995) LTD
HAVE
AGREED TO SEPARATE THEIR BUSINESSES
    * KNIGHT THERAPEUTICS - KNIGHT WILL SELL TO MEDISON GROUP
ALL OF
KNIGHT'S SHARES IN MEDISON, REFLECTING APPROXIMATELY 28.3% OF
SHARE CAPITAL OF MEDISON
    * KNIGHT THERAPEUTICS INC - KNIGHT WILL SELL TO MEDISON
GROUP ALL
OF KNIGHT'S SHARES IN MEDISON IN CONSIDERATION FOR C$77 MILLION
PAYABLE IN CASH
    * KNIGHT THERAPEUTICS INC - CO, MEDISON AGREED TO RELEASE
EACH
OTHER FROM ALL CLAIMS AND WITHDRAW ALL LEGAL PROCEEDINGS
INITIATED BY BOTH PARTIES
    * KNIGHT THERAPEUTICS INC - MEDISON AGREED TO A FOUR-YEAR
STANDSTILL COMMITMENT AND WILL DIVEST ITS POSITION IN KNIGHT
DURING THE FOUR-YEAR PERIOD
    * KNIGHT THERAPEUTICS INC - MEDISON, TOGETHER WITH ITS
AFFILIATES
OWN ABOUT 10.4 MILLION SHARES OR 7.5% OF KNIGHT

Source text for Eikon:  ID:nGNXbDxShL 
Further company coverage:  GUD.TO 

 ((Reuters.Briefs@thomsonreuters.com;))